Literature DB >> 10941190

Negative symptoms: the 'pathology' of motivation and goal-directed behaviour.

R G Brown1, G Pluck.   

Abstract

In many neurological and psychiatric disorders, including Alzheimer's disease and schizophrenia, symptoms are present that appear to reflect an essential absence of normal movement, cognition and emotional states. These negative symptoms might reflect fundamental impairments in basic brain mechanisms that underlie goal-directed behaviour. Knowledge of the pathology and pathophysiology of these diseases, combined with evidence from basic science, offers opportunities for understanding the neurobiological basis of goal-directed behaviour, particularly the interaction between limbic structures and striato-thalamo-cortical circuits. The study of patients with negative symptoms also provides opportunities for testing cognitive models of goal-directed behaviour, and eventually to map such models onto the neurobiology of both normal and abnormal behaviour.

Entities:  

Mesh:

Year:  2000        PMID: 10941190     DOI: 10.1016/s0166-2236(00)01626-x

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  71 in total

1.  Enhanced food-related motivation after bilateral lesions of the subthalamic nucleus.

Authors:  Christelle Baunez; Marianne Amalric; Trevor W Robbins
Journal:  J Neurosci       Date:  2002-01-15       Impact factor: 6.167

2.  Apathy in Parkinson's disease.

Authors:  G C Pluck; R G Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

3.  Apathy and depression: separate factors in Parkinson's disease.

Authors:  Lindsey Kirsch-Darrow; Michael Marsiske; Michael S Okun; Russell Bauer; Dawn Bowers
Journal:  J Int Neuropsychol Soc       Date:  2011-11       Impact factor: 2.892

4.  The prospective relationships among intrinsic motivation, neurocognition, and psychosocial functioning in schizophrenia.

Authors:  Eri Nakagami; Maanse Hoe; John S Brekke
Journal:  Schizophr Bull       Date:  2010-05-12       Impact factor: 9.306

Review 5.  REVIEW: Apathy diagnosis, assessment, and treatment in Alzheimer's disease.

Authors:  Philippe H Robert; Emmanuel Mulin; Patrick Malléa; Renaud David
Journal:  CNS Neurosci Ther       Date:  2010-10       Impact factor: 5.243

6.  Emotion and ocular responses in Parkinson's disease.

Authors:  J Dietz; M M Bradley; M S Okun; D Bowers
Journal:  Neuropsychologia       Date:  2011-08-04       Impact factor: 3.139

7.  A supramodal limbic-paralimbic-neocortical network supports goal-directed stimulus processing.

Authors:  Kristin R Laurens; Kent A Kiehl; Peter F Liddle
Journal:  Hum Brain Mapp       Date:  2005-01       Impact factor: 5.038

8.  The late positive potential, emotion and apathy in Parkinson's disease.

Authors:  J Dietz; M M Bradley; J Jones; M S Okun; W M Perlstein; D Bowers
Journal:  Neuropsychologia       Date:  2013-01-12       Impact factor: 3.139

9.  Recommendations for ICT use in Alzheimer's disease assessment: Monaco CTAD Expert Meeting.

Authors:  P H Robert; A Konig; S Andrieu; F Bremond; I Chemin; P C Chung; J F Dartigues; B Dubois; G Feutren; R Guillemaud; P A Kenisberg; S Nave; B Vellas; F Verhey; J Yesavage; P Mallea
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

10.  Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo.

Authors:  Garry D Honey; Philip R Corlett; Anthony R Absalom; Michael Lee; Edith Pomarol-Clotet; Graham K Murray; Peter J McKenna; Edward T Bullmore; David K Menon; Paul C Fletcher
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.